SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003339
Filing Date
2022-11-14
Accepted
2022-11-14 15:48:00
Documents
49
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220930x10q.htm   iXBRL 10-Q 1162239
2 EX-31.1 tmb-20220930xex31d1.htm EX-31.1 11907
3 EX-31.2 tmb-20220930xex31d2.htm EX-31.2 11919
4 EX-32.1 tmb-20220930xex32d1.htm EX-32.1 5740
5 EX-32.2 tmb-20220930xex32d2.htm EX-32.2 5893
  Complete submission text file 0001410578-22-003339.txt   5208566

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220930.xsd EX-101.SCH 45242
7 EX-101.CAL tmb-20220930_cal.xml EX-101.CAL 23093
8 EX-101.DEF tmb-20220930_def.xml EX-101.DEF 197558
9 EX-101.LAB tmb-20220930_lab.xml EX-101.LAB 348787
10 EX-101.PRE tmb-20220930_pre.xml EX-101.PRE 279965
43 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220930x10q_htm.xml XML 854013
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40119 | Film No.: 221384577
SIC: 6770 Blank Checks
Office of Real Estate & Construction